Cochrane COVID-19 Studienregister
Studienbericht
NCT05043129Erstmals veröffentlicht: 2021 Sept 14Letzte Aktualisierung: 2021 Sept 14

Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

  1. Studientyp
  2. Observational
  1. Studienziel
  2. Prevention
  1. Studiendesign
  2. Case series/Case control/Cohort
  1. Interventionszuordnung
  2. Not Applicable
Referenzdatensätze

Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection

NCT05043129
Eintrag in Studienregister
Keine Ergebnisse
On 11 February 2020, the International Committee for the Classification of Viruses named the disease caused by SARS-CoV-2 infection in humans as the new coronavirus pneumonia (coronavirus disease 2019, COVID-19). People infected with human immunodeficiency virus (HIV) are affected by their underlying diseases and are listed by the World Health Organization (WHO) as a high-risk population of SARS-CoV-2 infection.To evaluate the safety and effectiveness of COVID-19 vaccine in those patients with human immunodeficiency virus infection , and to guide the COVID-19 vaccination more scientifically, reasonably and effectively, this study was carried out